Migraine Market Analysis, Opportunities and Growth Report 2021 - PowerPoint PPT Presentation

About This Presentation
Title:

Migraine Market Analysis, Opportunities and Growth Report 2021

Description:

Complete report on Migraine industry spread across 66 pages with providing 4 company Profiles, 3 tables and 33 charts is now available at . – PowerPoint PPT presentation

Number of Views:13

less

Transcript and Presenter's Notes

Title: Migraine Market Analysis, Opportunities and Growth Report 2021


1
Global Migraine Market Industry Analysis
Outlook (2017-2021)
Published June 2017 Pages 66 Price US 800
(Single User License)
  • E-mail sales_at_marketreportsonline.com
  • Tel 1 888 391 5441

2
Global Migraine Market Industry Analysis
Outlook (2017-2021)
Migraine is a chronic neurovascular disorder
characterized by severe recurrent headaches. It
is one of the most common and most prevalent
disabling neurological conditions, characterized
by episodes often called migraine attacks. They
are quite different from regular headaches which
are non-migrainous. Migraineurs generally have a
lower threshold to triggers that might cause
neuronal hyperexcitability, including sleep
disturbances, environmental or emotional
challenges, alcohol exposure, diet, and hormonal
cycles/changes, among others. Migraine attacks
can cause significant pain for hours to days and
can be so severe that the pain is disabling.
Migraine headache is typically throbbing,
unilateral (one sided), and is aggravated by
physical activity. It typically presents with
additional symptoms in addition to headache pain,
including nausea, and sensitivity to light and/or
sound. Depending on symptoms, migraine is
broadly classified into two categories, Chronic
and Episodic. Migraines can be treated with two
types of drugs abortive and preventive. Abortive
medications are especially useful for people who
have nausea or vomiting related to their
migraine, and they work quickly. Preventive
treatment is considered if migraine occurs
frequently, typically more than one migraine per
week, or if migraine symptoms are severe. The
global migraine market is set to experience
favourable growth driven by factors such as
increasing female population increasing
cigarette consumption. Further, the scope of
growth for this market will be broadened by
rising healthcare expenditure and accelerating
economic growth. However, growth of this budding
market will be hindered by limitations of current
migraine therapies, regulatory challenges and
high cost associated with migraine
drugs. Complete report available at
http//www.marketreportsonline.com/594844.html.
3
Global Migraine Market Industry Analysis
Outlook (2017-2021)
  • The report Global Migraine Market Industry
    Analysis Outlook (2017-2021) analyses the
    development of this market, with focus majorly on
    the U.S. market. The major trends, growth drivers
    as well as issues being faced by the market are
    discussed in detail in this report. The four
    major players Amgen Inc., Eli Lilly and Company,
    Teva Pharmaceuticals Alder Biopharmaceuticals
    are being profiled along with their key
    financials and strategies for growth. The report
    contains a comprehensive analysis of the global
    migraine market along with the study of the
    regional markets.
  • Major Points from Table of Contents
  • Overview
  • 2. Global Market Analysis
  • 3. Regional Market
  • 4. Market Dynamics
  • 5. Competition
  • 6. Company Profiles
  • Purchase a copy of this research report at
    http//www.marketreportsonline.com/contacts/purcha
    se.php?name594844.

4
Global Migraine Market Industry Analysis
Outlook (2017-2021)
Few Points from List of Charts   Types of
MigraineGlobal Migraine Market by Value
(2012-2016)Global Migraine Market Forecast by
Value (2017-2021)Global Migraine Market by Drug
Type (2016)Global Therapeutic Botulinum Toxin
Market Forecast by Value (2016-2021)Global
Therapeutic Botulinum Toxin Market by Indication
(2016)The U.S. Total Migraine Population
(2016-2021)The U.S. Diagnosed and Treated Adult
Migraine Population (2016-2021)The U.S. Migraine
Population with CV Risk Factors (2016-2021)The
U.S. Migraine Treatment by Specialty (2016)The
U.S. Migraine Treated Population by Drug Type
(2016)The U.S. Acute Migraine Prescription
Volume (2016-2021)The U.S. Cambia Drug Revenue
(2016-2021)The U.S. Lasmiditan Drug Revenue
Treated Patients (2018-2022) The U.S. Alder Drug
Revenue (2019-2023)Europe Total Migraine and
Diagnosed Population (2016-2021)Europe Alder
Drug Revenue (2021-2025) Explore more
pharmaceuticals market research as well as other
newly published reports by Koncept Analytics at
http//www.marketreportsonline.com/publisher/konce
pt-analytics-market-research.html.
5
Global Migraine Market Industry Analysis
Outlook (2017-2021)
About Us MarketReportsOnline comprises of an
online library of 2,50,000 reports and in-depth
market research studies of over 5000 micro
markets. We provide 24/7 online and offline
support to our customers. Get in touch with us
for your needs of market research
reports. Contact Us Ritesh Tiwari 2nd Floor,
Metropole, Next to Inox Theatre, Bund Garden
Road, Pune, Maharashtra, India Tel 1 888 391
5441 E-mail sales_at_marketreportsonline.com
Write a Comment
User Comments (0)
About PowerShow.com